CC BY-NC-ND 4.0 · Asian J Neurosurg 2022; 17(02): 242-247
DOI: 10.1055/s-0042-1750838
Original Article

Risk Factors for Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage: A Tertiary Care Center Experience

Muhammad Mohsin Khan
1   Department of Neurosurgery, Hamad Medical Corporation, Doha, Qatar
,
Nissar Shaikh
2   Surgical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar
,
Zohaib Yousaf
3   Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar
,
Hussain Sultan
1   Department of Neurosurgery, Hamad Medical Corporation, Doha, Qatar
,
George Sadek
4   Weill Cornell Medicine, Education City, Al Luqta St, Ar-Rayyan, Qatar
,
Adnan Khan
1   Department of Neurosurgery, Hamad Medical Corporation, Doha, Qatar
,
Saadat Kamran
4   Weill Cornell Medicine, Education City, Al Luqta St, Ar-Rayyan, Qatar
5   Department of Neurology, Hamad Medical Corporation, Doha, Qatar
,
Ayman Z. Ahmed
5   Department of Neurology, Hamad Medical Corporation, Doha, Qatar
6   Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar
,
Walid Albanna
7   Department of Neurosurgery, RWTH Aachen University, Aachen, Germany
,
Sirajeddin Belkhair
1   Department of Neurosurgery, Hamad Medical Corporation, Doha, Qatar
6   Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar
,
Ali Ayyad
6   Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar
8   Department of Neurosurgery, Saarland University Hospital, Homburg, Germany
› Author Affiliations
Funding None.

Abstract

Objectives Cerebral vasospasm in subarachnoid hemorrhage (SAH) is associated with high morbidity and mortality. There is a lack of consensus on the risk factors leading to cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH). In this retrospective study, our objective was to determine the association of risk factors for cerebral vasospasm aSAH.

Methods A total of 259 charts of aSAH patients consecutively admitted to the surgical intensive care unit of Hamad General Hospital from January 2007 to December 2016 were reviewed and included. The patient's demographic data, including comorbidities like hypertension (HTN), was recorded. Variables of interest included measurements of the neurological deficit on admission, the severity of SAH, treatment modality, and the initial computerized tomography scan of the head for intraventricular hemorrhage, intracerebral hemorrhage, or hydrocephalus. Multivariate analysis and multiple logistic regression analyzed the relationship to identify the association of independent variables.

Results Out of the 259 patients, 34% (n = 87) suffered from cerebral vasospasm. The severity of SAH was associated with the development of cerebral vasospasm (p < 0.05). The presence of HTN and neurological deficits on admission were associated with an increased risk of cerebral vasospasm (p < 0.05, p < 0.01, respectively). Hydrocephalus requiring treatment using external ventricular drains decreased the risk of cerebral vasospasm (p < 0.05). Intraventricular and intracerebral hemorrhage were not associated with cerebral vasospasm (p = 0.25, p = 0.16). The endovascular treatment of cerebral aneurysms was associated with an increased risk of cerebral vasospasm (p < 0.05).

Conclusion Cerebral vasospasm is common among patients admitted with aSAH. It is significantly associated with the history of HTN, the neurological deficit on admission that corelates more strongly to the motor deficit on admission, the severity of hemorrhage (modified Fischer score), and endovascular treatment. External ventricular drainage was associated with a decrease in cerebral vasospasm. The present study's findings shed light on cerebral vasospasm's risk factors in the country and the region.



Publication History

Article published online:
24 August 2022

© 2022. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Sex, smoking, and risk for subarachnoid hemorrhage. Stroke 2016; 47 (08) 1975-1981
  • 2 Rumalla K, Smith KA, Arnold PM, Mittal MK. Subarachnoid hemorrhage and readmissions: national rates, causes, risk factors, and outcomes in 16,001 hospitalized patients. World Neurosurg 2018; 110: e100-e111
  • 3 Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354 (04) 387-396
  • 4 Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1999; 44 (06) 1237-1247 , discussion 1247–1248
  • 5 Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?. Neurosurg Focus 2006; 21 (03) E1
  • 6 Suarez JI, Qureshi AI, Yahia AB. et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 2002; 30 (06) 1348-1355
  • 7 Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg 1951; 8 (06) 660-667
  • 8 Pluta RM, Hansen-Schwartz J, Dreier J. et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31 (02) 151-158
  • 9 Magge SN, Chen HI, Ramakrishna R. et al. Association of a younger age with an increased risk of angiographic and symptomatic vasospasms following subarachnoid hemorrhage. J Neurosurg 2010; 112 (06) 1208-1215
  • 10 Mijiti M, Mijiti P, Axier A. et al. Incidence and predictors of angiographic vasospasm, symptomatic vasospasm and cerebral infarction in Chinese patients with aneurysmal subarachnoid hemorrhage. PLoS One 2016; 11 (12) e0168657
  • 11 Nassar HGE, Ghali AA, Bahnasy WS, Elawady MM. Vasospasm following aneurysmal subarachnoid hemorrhage: prediction, detection, and intervention. Egypt J Neurol Psychiat Neurosurg 2019; 55 (01) 3
  • 12 Dumont T, Rughani A, Silver J, Tranmer BI. Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care 2009; 11 (02) 183-189
  • 13 Mocco J, Ransom ER, Komotar RJ. et al. Racial differences in cerebral vasospasm: a systematic review of the literature. Neurosurgery 2006; 58 (02) 305-314
  • 14 Inagawa T. Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg 2016; 85: 56-76
  • 15 Kramer AH, Mikolaenko I, Deis N. et al. Intraventricular hemorrhage volume predicts poor outcomes but not delayed ischemic neurological deficits among patients with ruptured cerebral aneurysms. Neurosurgery 2010; 67 (04) 1044-1052 , discussion 1052–1053
  • 16 Yin L, Ma CY, Li ZK, Wang DD, Bai CM. Predictors analysis of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl (Wien) 2011; 110 (Pt 2): 175-178
  • 17 Inagawa T, Yahara K, Ohbayashi N. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2014; 54 (06) 465-473
  • 18 Frontera JA, Fernandez A, Schmidt JM. et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke 2009; 40 (06) 1963-1968
  • 19 Fang YJ, Mei SH, Lu JN. et al. New risk score of the early period after spontaneous subarachnoid hemorrhage: for the prediction of delayed cerebral ischemia. CNS Neurosci Ther 2019; 25 (10) 1173-1181
  • 20 Hirashima Y, Hamada H, Kurimoto M, Origasa H, Endo S. Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102 (05) 882-887
  • 21 Borkar SA, Singh M, Kale SS. et al. Spinal cerebrospinal fluid drainage for prevention of vasospasm in aneurysmal subarachnoid hemorrhage: a prospective, randomized controlled study. Asian J Neurosurg 2018; 13 (02) 238-246
  • 22 Chung DY, Mayer SA, Rordorf GA. External ventricular drains after subarachnoid hemorrhage: is less more?. Neurocrit Care 2018; 28 (02) 157-161
  • 23 Gruber A, Ungersböck K, Reinprecht A. et al. Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1998; 42 (02) 258-267 , discussion 267–268
  • 24 Malinova V, Schatlo B, Voit M, Suntheim P, Rohde V, Mielke D. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 2018; 129 (01) 84-90
  • 25 Li H, Pan R, Wang H. et al. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis. Stroke 2013; 44 (01) 29-37
  • 26 Ibrahim GM, Vachhrajani S, Ilodigwe D. et al. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage. Neurosurgery 2012; 70 (01) 102-109 , discussion 109